- Home
- MSEX vs MDXG Comparison
MSEX vs MDXG Comparison
Compare MSEX & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MSEX | MDXG |
|---|---|---|
| Founded | 1897 | 2006 |
| Country | United States | United States |
| Employees | 395 | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 530.2M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | MSEX | MDXG |
|---|---|---|
| Price | $50.68 | $3.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $61.33 | $9.00 |
| AVG Volume (30 Days) | 106.2K | ★ 1.9M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.77% | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | $10.60 | N/A |
| Revenue Next Year | $10.94 | $13.02 |
| P/E Ratio | $22.68 | ★ N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $44.94 | $3.03 |
| 52 Week High | $62.18 | $7.99 |
Technical Indicators
Market Signals| Indicator | MSEX | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 39.55 | 47.00 |
| Support Level | $49.92 | $3.11 |
| Resistance Level | $54.71 | $7.39 |
| Average True Range (ATR) | 1.27 | 0.16 |
| MACD | -0.06 | 0.04 |
| Stochastic Oscillator | 7.85 | 78.01 |
Price Performance
Historical ComparisonAbout MSEX Middlesex Water Company
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.